Recent Posts

• January 15, 2025

  Seminar in Luxembourg

  On January 17, Mariike will be giving a seminar at the Causal Analysis of Biomedical Data seminar series, University of Luxembourg. More information: here.

• January 14, 2025

  New group member

  We are very excited to announce that Olavi Goussev has joined Kuijjer group at University of Helsinki as iCANDOC student. Olavi has a degree in Computer Science and Engineering from Aalto University and performed Master's thesis work in the group of collaborator Anniina Färkkilä at University of Helsinki. Olavi will be developing a deep learning approach to detect enhancer-promoter interactions in cancer.

• January 14, 2025

  Associate professor in Cancer Data Science at University of Helsinki

  As per January 1, 2025, Mariike has started as iCAN Associate Professor in Cancer Data Science at the department of Biochemistry and Developmental Biology, University of Helsinki, Finland, where she is establishing a new group. In the spring semester of 2025, she will work 50% in Oslo and Helsinki to allow for a smooth transition. Read the interview here.

• November 29, 2024

  New visiting PhD student

  We are happy to announce that Thomas-Sylvestre Michau has joined Kuijjer group on a 3-week research visit. Thomas-Sylvestre is a PhD student in the group of our collaborator Maud Fagny, where he works on single-sample network modeling of cis-regulatory interactions in maize response to drought. His visit will include joining the group's regular meetings, as well as participating in our multi-omics data integration for precision medicine course, and...

• November 19, 2024

  New group member

  We are very excited to announce that Parastoo Shahrouzi (Paris) has joined Kuijjer group to establish the group's wet-lab arm! Paris has a degree in functional cancer genomics from the University of Basque Country, Spain, after which she joined our collaborator Vessela Kristensen's group at Oslo University Hospital on a Marie Curie Scientia II postdoctoral fellowship. Paris will be working on validating regulatory alterations driving breast cancer heterogeneity and...